Cancer and neoplasms
Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus
Sep
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Google Scholar
Barba D, León-Sosa A, Lugo P, Suquillo D, Torres F, Surre F, et al. Breast cancer, screening and diagnostic tools: all you need to know. Crit Rev Oncol Hematol. 2021;157: 103174.
Google Scholar
Shen S, Zhou Y, Xu Y, Zhang B, Duan X, Huang R, et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer. 2015;112(6):998–1004. https://doi.org/10.1038/bjc.2015.33. PMID: 25668012; PMCID: PMC4366890.
Lim YX, Lim ZL, Ho PJ, Li J. Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives. Cancers. 2022;14(17):4218.
Google Scholar
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening—viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353–8.
Google Scholar
Rahmat K, Mumin NA, Hamid MT, Hamid SA, Ng WL. MRI breast: current imaging trends, clinical applications, and future research directions. Curr Med Imaging. 2022;18(13):1347–61.
Google Scholar
Monticciolo DL, Malak SF, Friedewald SM, Eby PR, Newell MS, Moy L, et al. Breast cancer screening recommendations inclusive of all women at average risk: update from the ACR and Society of Breast Imaging. J Am Coll Radiol. 2021;18(9):1280–8.
Google Scholar
Engel JM, Stankowski-Drengler TJ, Stankowski RV, Liang H, Doi SA, Onitilo AA. All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. Am J Roentgenol. 2015;204(4):898–902.
Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, et al. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study). Cancer Causes Control. 2022;33:125–36.
Google Scholar
Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med. 2016;164(4):244–55.
Google Scholar
Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 2017;14(9):1137–43.
Google Scholar
Basu P, Zhang L, Hariprasad R, Carvalho AL, Barchuk A. A pragmatic approach to tackle the rising burden of breast cancer through prevention & early detection in countries ‘in transition.’ Indian J Med Res. 2020;152(4):343.
Google Scholar
Meattini I, Livi L, Lorito N, Becherini C, Bacci M, Visani L, et al. Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside. Cancer Treat Rev. 2022;108:102417. https://doi.org/10.1016/j.ctrv.2022.102417. Epub 2022 May 21. PMID: 35623219.
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih Y-CT, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. Jama. 2015;314(15):1599–614.
Zou Z, Cini K, Dong B, Ma Y, Ma J, Burgner DP, et al. Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation. 2020;141(10):790–9.
Google Scholar
Arapova EY. The “BRICS Plus” as the first international platform connecting regional trade agreements. Asia Pac Soc Sci Rev. 2019;19(2):30–46.
Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo CM, et al. Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): a population-based comparison. Cancer Epidemiol. 2018;53:27–34.
Google Scholar
Mubarik S, Luo L, Iqbal M, Nawsherwan, Bai J, Yu C. More recent insights into the breast cancer burden across BRICS-Plus: Health consequences in key nations with emerging economies using the global burden of disease study 2019. Front Oncol. 2023;13:1100300. https://doi.org/10.3389/fonc.2023.1100300. PMID: 36761973; PMCID: PMC9902930.
Grimm LJ, Avery CS, Hendrick E, Baker JA. Benefits and risks of mammography screening in women ages 40 to 49 years. J Prim Care Community Health. 2022;13:21501327211058320.
Google Scholar
DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008;15(4):408–16.
Google Scholar
Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2020. Available at: https://vizhub.healthdata.org/gbd-results/. (Accessed 1st January 2023).
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study (vol 76, pg 2982, 2020). J Am Coll Cardiol. 2021;77(15):1958–9.
Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420–44.
Google Scholar
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1736–88.
Google Scholar
Flaxman AD, Vos DT, Murray CJ. An integrative metaregression framework for descriptive epidemiology: University of Washington Press; 2015.
Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2129–43.
Google Scholar
Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712–23.
Google Scholar
Anonymous. New country classifications by income level: 2018–2019. World Bank Blogs Available at: https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2018-2019.
Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.
Google Scholar
Youn HJ, Han W. A review of the epidemiology of breast cancer in Asia: focus on risk factors. Asian Pac J Cancer Prev. 2020;21(4):867.
Google Scholar
Ellingjord-Dale M, Vos L, Vik Hjerkind K, Hjartåker A, Russnes HG, Tretli S, et al. Number of risky lifestyle behaviors and breast cancer risk. JNCI Cancer Spectr. 2018;2(3):pky030.
Ellingjord-Dale M, Vos L, Hjerkind KV, Hjartåker A, Russnes HG, Tretli S, et al. Alcohol, physical activity, smoking, and breast cancer subtypes in a large, nested case–control study from the Norwegian Breast Cancer Screening Program. Cancer Epidemiol Biomark Prev. 2017;26(12):1736–44.
Google Scholar
Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1(5):611–21.
Google Scholar
Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, et al. Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. Breast Cancer Res Treat. 2020;182(1):215–27.
Google Scholar
Ribeiro ALP, Duncan BB, Brant LC, Lotufo PA, Mill JG, Barreto SM. Cardiovascular health in Brazil: trends and perspectives. Circulation. 2016;133(4):422–33.
Google Scholar
Starodubov VI, Marczak LB, Varavikova E, Bikbov B, Ermakov SP, Gall J, et al. The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10153):1138–46.
Google Scholar
Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med. 2006;3(2): e18.
Google Scholar
Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.
Google Scholar
Observatory. GH. Existence of national screening program for breast cancer. . Geneva, Switzerland: World Health Organization Available at: https://www.who.int/data/gho/indicator-metadata-registry/.
Molassiotis A, Tyrovolas S, Giné-Vázquez I, Yeo W, Aapro M, Herrstedt J. Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries. ESMO Open. 2021;6(3): 100111.
Google Scholar
Cancer/WHO. IAfRo. Chapter 3, Screening Programmes. In: Breast Cancer Screening Volume 15. Lyon France: IARC; 2016. 165–236.
Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening programmes as of March 2014. Int J Oncol. 2014;45(5):1785–92.
Google Scholar
Peintinger F. National breast screening programs across Europe. Breast Care. 2019;14(6):354–8.
Google Scholar
Altobelli E, Rapacchietta L, Angeletti PM, Barbante L, Profeta FV, Fagnano R. Breast cancer screening programmes across the WHO European region: differences among countries based on national income level. Int J Environ Res Public Health. 2017;14(4):452.
Google Scholar
Green M, Raina V. Epidemiology, screening and diagnosis of breast cancer in the Asia-Pacific region: current perspectives and important considerations. Asia Pac J Clin Oncol. 2008;4:S5–13.
Google Scholar
Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in Asia. Breast care. 2015;10(6):372–8.
Google Scholar
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027–37.
Google Scholar
Caballero FF, Soulis G, Engchuan W, Sánchez-Niubó A, Arndt H, Ayuso-Mateos JL, et al. Advanced analytical methodologies for measuring healthy ageing and its determinants, using factor analysis and machine learning techniques: the ATHLOS project. Sci Rep. 2017;7(1):1–13.
Google Scholar
Zhao Y, Tan YS, Aupperlee MD, Langohr IM, Kirk EL, Troester MA, et al. Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res. 2013;15(5):1–20.
Google Scholar
Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, et al. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med. 2016;14(1):1–15.
Google Scholar
Tan M-M, Ho W-K, Yoon S-Y, Mariapun S, Hasan SN, Lee DS-C, et al. A case-control study of breast cancer risk factors in 7,663 women in Malaysia. PloS One. 2018;13(9):e0203469.
Mubarik S, Liu X, Malik SS, Wang L, Yu Y, Yu C. Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis. Environ Sci Pollut Res. 2021;28(36):49864–76.
Google Scholar
Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6. https://doi.org/10.1017/S002966510800712X. Epub 2008 May 1. PMID: 18452640.
Lv L, Zhao B, Kang J, Li S, Wu H. Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Front Public Health. 2023;10:1078191. https://doi.org/10.3389/fpubh.2022.1078191. PMID: 36726635; PMCID: PMC9884979.
Yan X-X, Zhu J, Li Y-J, Cao M-D, Wang X, Wang H, et al. Estimating disability-adjusted life years for breast cancer and the impact of screening in female populations in China, 2015–2030: an exploratory prevalence-based analysis applying local weights. Popul Health Metrics. 2022;20(1):1–11.
Google Scholar
Mubarik S, Wang F, Nadeem AA, Fawad M, Yu C. Breast cancer epidemiology and sociodemographic differences in BRICS-plus countries from 1990 to 2019: An age period cohort analysis. SSM Popul Health. 2023;22:101418. https://doi.org/10.1016/j.ssmph.2023.101418. PMID: 37215157; PMCID: PMC10193025.
Mann RM, Athanasiou A, Baltzer PA, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32(6):4036–45.
Google Scholar
Veitch D, Goossens R, Owen H, Veitch J, Molenbroek J, Bochner M. Evaluation of conventional training in Clinical Breast Examination (CBE). Work. 2019;62(4):647–56.
Google Scholar
